93 related articles for article (PubMed ID: 30226612)
21. EphA4 receptor, overexpressed in pancreatic ductal adenocarcinoma, promotes cancer cell growth.
Iiizumi M; Hosokawa M; Takehara A; Chung S; Nakamura T; Katagiri T; Eguchi H; Ohigashi H; Ishikawa O; Nakamura Y; Nakagawa H
Cancer Sci; 2006 Nov; 97(11):1211-6. PubMed ID: 16965393
[TBL] [Abstract][Full Text] [Related]
22. Effects of RUNX3 mediated Notch signaling pathway on biological characteristics of colorectal cancer cells.
Li H; Li D; Meng N
Int J Oncol; 2017 Jun; 50(6):2059-2068. PubMed ID: 28498402
[TBL] [Abstract][Full Text] [Related]
23. High expression of AFAP1-AS1 is associated with poor survival and short-term recurrence in pancreatic ductal adenocarcinoma.
Ye Y; Chen J; Zhou Y; Fu Z; Zhou Q; Wang Y; Gao W; Zheng S; Zhao X; Chen T; Chen R
J Transl Med; 2015 Apr; 13():137. PubMed ID: 25925763
[TBL] [Abstract][Full Text] [Related]
24. Nuclear expression of Y-box binding protein-1 is associated with poor prognosis in patients with pancreatic cancer and its knockdown inhibits tumor growth and metastasis in mice tumor models.
Shinkai K; Nakano K; Cui L; Mizuuchi Y; Onishi H; Oda Y; Obika S; Tanaka M; Katano M
Int J Cancer; 2016 Jul; 139(2):433-45. PubMed ID: 26939718
[TBL] [Abstract][Full Text] [Related]
25. HIF-2α regulates non-canonical glutamine metabolism via activation of PI3K/mTORC2 pathway in human pancreatic ductal adenocarcinoma.
Li W; Chen C; Zhao X; Ye H; Zhao Y; Fu Z; Pan W; Zheng S; Wei L; Nong T; Li Z; Chen R
J Cell Mol Med; 2017 Nov; 21(11):2896-2908. PubMed ID: 28544376
[TBL] [Abstract][Full Text] [Related]
26. Negative control of TRAIL-R1 signaling by transforming growth factor β1 in pancreatic tumor cells involves Smad-dependent down regulation of TRAIL-R1.
Radke DI; Ungefroren H; Helm O; Voigt S; Alp G; Braun H; Hübner S; Dilchert J; Sebens S; Adam D; Kalthoff H; Trauzold A
Cell Signal; 2016 Nov; 28(11):1652-62. PubMed ID: 27492861
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA‑539 inhibits cell proliferation, colony formation and invasion in pancreatic ductal adenocarcinoma by directly targeting IGF‑1R.
Lin Y; Rong L; Zhao J; Lin R; Li S
Mol Med Rep; 2018 Aug; 18(2):1804-1811. PubMed ID: 29901181
[TBL] [Abstract][Full Text] [Related]
28. Notch signaling molecule is involved in the invasion of MiaPaCa2 cells induced by CoCl2 via regulating epithelial‑mesenchymal transition.
Chen DW; Wang H; Bao YF; Xie K
Mol Med Rep; 2018 Apr; 17(4):4965-4972. PubMed ID: 29393429
[TBL] [Abstract][Full Text] [Related]
29. FAM83D knockdown regulates proliferation, migration and invasion of colorectal cancer through inhibiting FBXW7/Notch-1 signalling pathway.
Mu Y; Zou H; Chen B; Fan Y; Luo S
Biomed Pharmacother; 2017 Jun; 90():548-554. PubMed ID: 28407575
[TBL] [Abstract][Full Text] [Related]
30. Association between high levels of Notch3 expression and high invasion and poor overall survival rates in pancreatic ductal adenocarcinoma.
Zhou JX; Zhou L; Li QJ; Feng W; Wang PM; Li EF; Gong WJ; Kou MW; Gou WT; Yang YL
Oncol Rep; 2016 Nov; 36(5):2893-2901. PubMed ID: 27633819
[TBL] [Abstract][Full Text] [Related]
31. Notch1 downregulation combined with interleukin-24 inhibits invasion and migration of hepatocellular carcinoma cells.
Han B; Liu SH; Guo WD; Zhang B; Wang JP; Cao YK; Liu J
World J Gastroenterol; 2015 Sep; 21(33):9727-35. PubMed ID: 26361419
[TBL] [Abstract][Full Text] [Related]
32. The adaptor protein CrkII regulates IGF-1-induced biological behaviors of pancreatic ductal adenocarcinoma.
Liu R; Wang Q; Xu G; Li K; Zhou L; Xu B
Tumour Biol; 2016 Jan; 37(1):817-22. PubMed ID: 26250463
[TBL] [Abstract][Full Text] [Related]
33. MUC1-C dictates neuroendocrine lineage specification in pancreatic ductal adenocarcinomas.
Luan Z; Morimoto Y; Fushimi A; Yamashita N; Suo W; Bhattacharya A; Hagiwara M; Jin C; Kufe D
Carcinogenesis; 2022 Feb; 43(1):67-76. PubMed ID: 34657147
[TBL] [Abstract][Full Text] [Related]
34. Notch1 functions as a tumor suppressor in a model of K-ras-induced pancreatic ductal adenocarcinoma.
Hanlon L; Avila JL; Demarest RM; Troutman S; Allen M; Ratti F; Rustgi AK; Stanger BZ; Radtke F; Adsay V; Long F; Capobianco AJ; Kissil JL
Cancer Res; 2010 Jun; 70(11):4280-6. PubMed ID: 20484026
[TBL] [Abstract][Full Text] [Related]
35. CDK5 positively regulates Notch1 signaling in pancreatic cancer cells by phosphorylation.
Chu Q; Wang L; Zhang J; Wang W; Wang Y
Cancer Med; 2021 Jun; 10(11):3689-3699. PubMed ID: 33960694
[TBL] [Abstract][Full Text] [Related]
36. High expression of ErbB3 binding protein 1 (EBP1) predicts poor prognosis of pancreatic ductal adenocarcinoma (PDAC).
Gong C; Zhang Y; Chen Y; Zhang H; Liu X; Xue H; Ji L; Wang L; Yang L; Zhou G; Wan C
Tumour Biol; 2015 Dec; 36(12):9189-99. PubMed ID: 26088450
[TBL] [Abstract][Full Text] [Related]
37. Expression and functional perspectives of miR-184 in pancreatic ductal adenocarcinoma.
Li H; Xiang H; Ge W; Wang H; Wang T; Xiong M
Int J Clin Exp Pathol; 2015; 8(10):12313-8. PubMed ID: 26722418
[TBL] [Abstract][Full Text] [Related]
38. Monocarboxylate Transporters MCT1 and MCT4 Regulate Migration and Invasion of Pancreatic Ductal Adenocarcinoma Cells.
Kong SC; Nøhr-Nielsen A; Zeeberg K; Reshkin SJ; Hoffmann EK; Novak I; Pedersen SF
Pancreas; 2016 Aug; 45(7):1036-47. PubMed ID: 26765963
[TBL] [Abstract][Full Text] [Related]
39. Significance of expression of glucagon-like peptide 1 receptor in pancreatic cancer.
Cases AI; Ohtsuka T; Kimura H; Zheng B; Shindo K; Oda Y; Mizumoto K; Nakamura M; Tanaka M
Oncol Rep; 2015 Oct; 34(4):1717-25. PubMed ID: 26238361
[TBL] [Abstract][Full Text] [Related]
40. KIAA1199 is induced by inflammation and enhances malignant phenotype in pancreatic cancer.
Kohi S; Sato N; Koga A; Matayoshi N; Hirata K
Oncotarget; 2017 Mar; 8(10):17156-17163. PubMed ID: 28179576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
